VBio Experts: A Tripartite Agreement Between voxsight, BioMaje and France Europe Innovation (FEI) to Support European Human and Animal Health Innovation Projects

4 days ago

2 min read

Updated: 2 hours ago

26 October 2026

France Europe Innovation (FEI), voxsight and BioMaje announce a tripartite agreement aimed at pooling their expertise and strengthening their advisory support for stakeholders in human and animal health innovation.

This partnership aims to provide companies, research laboratories and healthcare stakeholders with comprehensive support in preparing innovative Horizon Europe project proposals.

It brings together three complementary areas of expertise.

France Europe Innovation (FEI) – Expertise in Developing Innovative European Collaborative Projects

Founded in 1999 by engineer Olivier Degrand, France Europe Innovation has been supporting research and innovation stakeholders in the development, funding and coordination of collaborative projects for over 25 years. Its expertise notably covers the Horizon Europe programme.

FEI has extensive experience in the healthcare sector, gained through its involvement in numerous European projects, including SERENA (Horizon Europe), PHAGOBURN (FP7-HEALTH-2013), LEUKOTREAT (FP7-HEALTH-2009), TRIAD (FP7-HEALTH-2011), LOULLA & PHILLA (FP7-HEALTH-2007) and KIDSCANCERKINOME (FP6-2005-LIFESCIHEALTH).

As part of the preparation of a Horizon Europe proposal, FEI will contribute its expertise in the design and development of European collaborative projects.

voxsight – Expertise in market intelligence and innovation valuation

Led by Olivier Cotten, voxsight (formerly The MarkeTech Group) has been developing expertise in marketing, market intelligence and consultancy in the healthcare sector since 2003, with in-depth knowledge of the MedTech, Pharma and Biotech industries and innovation dynamics.

voxsight specialises in assessing the market potential of innovations, supporting the valorisation of projects arising from academic research, and conducting strategic market studies.

As part of the preparation of a Horizon Europe proposal, voxsight will contribute its expertise to drafting Section 2, Impact, of the proposal preparation canvas.

BioMaJe Conseil – Scientific expertise, R&D strategy and clinical development

Founded in 2020 by Dr Jérôme Gabard, BioMaje supports life sciences stakeholders in their research and development strategies, clinical development and regulatory affairs. Drawing on extensive international experience in industry and consulting, Jérôme Gabard has also founded two start-ups in the medical field.

He was co-coordinator of the European project PHAGOBURN, funded under the Seventh Framework Programme (FP7), and contributed to other European projects involving Pherecydes Pharma, including PHAGOPROD, funded by Horizon 2020.

As part of the preparation of a Horizon Europe proposal, BioMaje will contribute its expertise to drafting Section 1, Impact, of the proposal preparation canvas, and to structuring the project as described in Section 3, Quality and Efficiency of the Implementation.

An integrated approach, from innovation to European funding

By combining their respective capabilities, the three partners aim to provide coherent, tailored support addressing the specific needs of healthcare projects, including: